(VIANEWS) – Shares of Merrimack Pharmaceuticals (MACK) dropped 5.64% to $5.02 at 11:34 EST on Tuesday, after two sequential sessions in a row of losses. NASDAQ Composite is dropping 0.4% to $14,621.90, following the last session’s upward trend. This seems, as yet, a somewhat negative trend trading session today.
Merrimack Pharmaceuticals’s last close was $5.60, 40.74% under its 52-week high of $9.45.
Today’s last reported volume for Merrimack Pharmaceuticals is 12108 which is 51.19% below its average volume of 24807.
Merrimack Pharmaceuticals’s last week, last month’s, and last quarter’s current volatility was a positive 0.29%, a negative 0.05%, and a positive 1.75%, respectively.
Merrimack Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.82% (last week), 1.30% (last month), and 1.75% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Merrimack Pharmaceuticals’s stock is considered to be overbought (>=80).
Merrimack Pharmaceuticals’s Stock Yearly Top and Bottom Value
Merrimack Pharmaceuticals’s stock is valued at $5.02 at 11:34 EST, way under its 52-week high of $9.45 and way higher than its 52-week low of $3.24.
Merrimack Pharmaceuticals’s Moving Average
Merrimack Pharmaceuticals’s value is way under its 50-day moving average of $6.28 and way under its 200-day moving average of $6.73.
More news about Merrimack Pharmaceuticals (MACK).